New daily pill shows promise for Tough-to-Treat cancers
Disease control
Recruiting now
This study tests a new daily pill, ABP1011T, in people with advanced solid tumors like small cell lung cancer, esophageal cancer, cervical cancer, bladder cancer, and renal cell carcinoma. Participants take one tablet each day on an empty stomach in 21-day cycles. The goal is to …
Phase: PHASE2 • Sponsor: Shanghai AB PharmaTech Ltd. • Aim: Disease control
Last updated May 13, 2026 15:59 UTC